Quantinno Capital Management LP Increases Holdings in Relx Plc (NYSE:RELX)

Quantinno Capital Management LP grew its stake in Relx Plc (NYSE:RELX - Free Report) by 11.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 171,219 shares of the technology company's stock after purchasing an additional 17,543 shares during the period. Quantinno Capital Management LP's holdings in Relx were worth $7,777,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Franklin Resources Inc. increased its position in shares of Relx by 3.3% in the third quarter. Franklin Resources Inc. now owns 18,429 shares of the technology company's stock valued at $873,000 after buying an additional 588 shares in the last quarter. Park Avenue Securities LLC raised its position in Relx by 48.3% during the fourth quarter. Park Avenue Securities LLC now owns 61,173 shares of the technology company's stock worth $2,778,000 after acquiring an additional 19,912 shares during the period. Heritage Family Offices LLP lifted its holdings in Relx by 15.8% during the fourth quarter. Heritage Family Offices LLP now owns 24,632 shares of the technology company's stock valued at $1,119,000 after purchasing an additional 3,366 shares in the last quarter. Ritholtz Wealth Management grew its position in shares of Relx by 0.5% in the fourth quarter. Ritholtz Wealth Management now owns 148,234 shares of the technology company's stock valued at $6,733,000 after purchasing an additional 781 shares during the period. Finally, Merit Financial Group LLC acquired a new stake in shares of Relx in the fourth quarter valued at about $301,000. Institutional investors and hedge funds own 15.02% of the company's stock.

Analysts Set New Price Targets

Several research analysts recently weighed in on the stock. StockNews.com downgraded shares of Relx from a "buy" rating to a "hold" rating in a research report on Tuesday, March 4th. Barclays raised Relx from an "equal weight" rating to an "overweight" rating in a report on Friday, March 14th. Morgan Stanley restated an "overweight" rating on shares of Relx in a research report on Wednesday, April 16th. Finally, The Goldman Sachs Group initiated coverage on Relx in a research report on Wednesday, March 26th. They set a "buy" rating for the company. One analyst has rated the stock with a hold rating, four have assigned a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Buy".

Relx Price Performance

Shares of NYSE:RELX traded down $0.06 during midday trading on Tuesday, hitting $54.97. The company's stock had a trading volume of 444,763 shares, compared to its average volume of 690,571. The company has a market cap of $101.47 billion, a P/E ratio of 29.55, a price-to-earnings-growth ratio of 2.73 and a beta of 0.86. Relx Plc has a 12-month low of $43.28 and a 12-month high of $55.21. The business's 50 day simple moving average is $51.28 and its 200 day simple moving average is $48.98. The company has a debt-to-equity ratio of 1.46, a quick ratio of 0.47 and a current ratio of 0.52.

Relx Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.